SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-029221
Filing Date
2024-03-11
Accepted
2024-03-11 16:05:15
Documents
15
Period of Report
2024-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K olma-20240311.htm   iXBRL 8-K 40042
2 EX-99.1 olma-ex99_1.htm EX-99.1 37605
3 GRAPHIC img39466132_0.jpg GRAPHIC 35214
4 GRAPHIC img39466132_1.jpg GRAPHIC 127299
  Complete submission text file 0000950170-24-029221.txt   422569

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT olma-20240311.xsd EX-101.SCH 24997
16 EXTRACTED XBRL INSTANCE DOCUMENT olma-20240311_htm.xml XML 4749
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 24737956
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)